Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL326P is a human pseudogene derived from the 7SL RNA gene, which normally encodes the RNA component of the signal recognition particle (SRP), a ribonucleoprotein involved in targeting secretory proteins to the endoplasmic reticulum during translation[1][3][5][6]. Unlike functional SRP RNA genes, RN7SL326P is a truncated, likely non-functional genomic sequence that arose through retrotransposition of 7SL RNA back into DNA. Hundreds of 7SL pseudogenes like RN7SL326P are dispersed in the human genome, none of which are known to encode active RNA[1][3]. While some pseudogenes can be transcribed and participate in regulation by acting as competing endogenous RNAs or by generating small regulatory RNAs[2][4], no specific function or clinical relevance has been reported for RN7SL326P. Summary: RN7SL326P is a non-coding pseudogene derived from the 7SL RNA gene, not a functional receptor, enzyme, or other therapeutic target, with no known role in physiology or disease, and with no drug interactions or biomarker utility[1][3][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 326, pseudogene (RN7SL326P).